Weight loss drug rejected by FDA advisers

As I wrote on a few days ago, a new weight-loss drug by Sanofi-Aventis has ben under heavy scrutiny by psychiatric professionals based on the side effects of the drug on mood, behavior and psychiatric problems.

It seems that the FDA could not overcome the publicity from the drug's side effects, as a panel from that agency unanimously rejected the drug based almost completely on its side effects.

This is not a first time -- as I believe more drugs cause more harm than good these days, as they solve one problem (possibly) while creating a huge other problem. That is certainly the case here.